Jason Box
Nurse Practitioner · Leakesville, MSNPI 1851448906
Payments from drug & device makers
Across 116 payments — averaging $13.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$688
- Otsuka America Pharmaceutical, Inc.$234
- Novo Nordisk$193
- AstraZeneca$97
- Lilly USA, LLC$42
- Abbott$29
- plus $270 from 15 others
What the payments were for
- Food & beverage$1,551100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$1,551 in reported general payments places this provider in the 80th percentile of 1,090 nurse practitioner providers in Mississippi.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| FarxigaDapagliflozin Propanediol | 196 | $117,931 |
| OzempicSemaglutide | 97 | $88,835 |
| EliquisApixaban | 106 | $69,381 |
| MounjaroTirzepatide | 62 | $64,761 |
| VraylarCariprazine Hcl | 37 | $44,239 |
| Tresiba Flextouch U-200Insulin Degludec | 62 | $41,634 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 46 | $35,635 |
| RybelsusSemaglutide | 24 | $31,449 |
| JardianceEmpagliflozin | 49 | $28,986 |
| XareltoRivaroxaban | 51 | $28,345 |
| RexultiBrexpiprazole | 23 | $21,918 |
| TrulicityDulaglutide | 25 | $20,661 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 26 | $18,249 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 18 | $15,412 |
| LinzessLinaclotide | 29 | $15,060 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaFarxiga, Breztri Aerosphere, Symbicort | $97 | $156,827256 claims |
| Novo NordiskOzempic, Rybelsus | $193 | $120,283121 claims |
| Lilly USA, LLCMounjaro, Trulicity | $42 | $85,42287 claims |
| PfizerEliquis | $13 | $69,381106 claims |
| AbbVieVraylar, Linzess, Synthroid | $688 | $63,488135 claims |
| GSKTrelegy Ellipta, Breo Ellipta, Shingrix | $14 | $23,29546 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $234 | $21,91823 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $22 | $15,05343 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 1,090 nurse practitioner providers in Mississippi.
Other nurse practitioner in Leakesville
- Christina TreppendahlRidgeland$673K
- Catherine WellsJackson$75K
- Jo Anna WarrenJackson$73K
- Marisa StringerBiloxi$68K
- Sara KlausFlowood$48K
- Micaela PerkinsOxford$32K
- Michelle TharpJackson$28K
- Kaylon LewisHattiesburg$25K
- Jennifer HollyJackson$16K
- Mariah CoxGulfport$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.